Goldys was Deputy Director of the ARC Centre of Excellence for Nanoscale BioPhotonics and now leads a nanoscale biophotonics group in Biomedical Engineering. The programme is about extracting diagnostic information from very weak optical signals inside cells and tissue: luminescent and upconverting nanoparticle probes with long lifetimes that allow time-gated, background-free detection; hyperspectral unmixing of native cellular autofluorescence (NADH, FAD, porphyrins) as a completely label-free readout of cell state, which she has pushed toward clinical use in reproductive medicine and cancer; and nanoparticle-mediated therapy. Positioned against the established body of NV-ensemble quantum sensing work — DEER, nanoscale NMR and T1 relaxometry protocols operating at pT/sqrt(Hz) field sensitivity — time-gated luminescence and NV relaxometry are two solutions to the same problem — how to read a faint, specific signal out of an autofluorescent, optically hostile biological background — and her clinical translation experience is exactly the missing capability in most quantum-biosensing groups. Preferred attribute present: advanced/label-based imaging with a genuine human-application pathway.

Weil directs the Synthesis of Macromolecules department at the MPI for Polymer Research in Mainz (co-located with JGU, with which the department collaborates closely). The quantum-sensing core of her programme is nanodiamond: in 2026 her group published a bottom-up route that converts molecularly defined nanographenes into ultrasmall, size-uniform nanodiamonds under HPHT, incorporating SiV and GeV colour centres during synthesis rather than by post-hoc implantation -- addressing the long-standing problem that milled detonation nanodiamonds have poor size control and damaged surfaces. Alongside this sits a mature nanodiamond biosensing line: surface bioconjugation and nanogel encapsulation, T1 relaxometry for free-radical detection in single mitochondria and in cells, nanoscale thermometry and photothermal theranostics. Relative to the established NV-ensemble quantum-sensing playbook (DEER, nanoscale NMR, T1 relaxometry at pT/sqrt(Hz) ensemble sensitivity), this group is attacking the material bottleneck directly -- if you want NV/SiV ensembles with controlled size, surface and coherence for in-cell sensing, this is the synthesis end of that pipeline, and it feeds spin-readout collaborators at Ulm (Jelezko/Kubanek).